Crossmark

Expectancies as predictors of symptom improvement after antimicrobial therapy for persistent symptoms attributed to Lyme disease

Published Online: 2021-05-24

Published Print: 2021-10

Authors

van Middendorp, Henriët https://orcid.org/0000-0003-4575-0895
Berende, Anneleen https://orcid.org/0000-0002-9079-9519
Vos, Fidel J.

ter Hofstede, Hadewych H. M.

Kullberg, Bart Jan

Evers, Andrea W. M. https://orcid.org/0000-0002-0090-5091
License Information

Text and Data Mining valid from 2021-05-24

Version of Record valid from 2021-05-24
More Information

Article History

Received: 20 December 2020

Revised: 29 April 2021

Accepted: 2 May 2021

First Online: 24 May 2021

Declarations

:

: The study was ethically approved by the Medical Ethics Review Committee CMO Region Arnhem-Nijmegen (registration number 2009/187, NL27344.091.09). This study was performed in line with the principles of the Declaration of Helsinki.

: All participants provided written informed consent to be included in the study and their aggregated data to be used for scientific publications.

: None.

Document is current